Ladislav Machala

1.5k total citations
40 papers, 757 citations indexed

About

Ladislav Machala is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ladislav Machala has authored 40 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 18 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Ladislav Machala's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (13 papers). Ladislav Machala is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (13 papers). Ladislav Machala collaborates with scholars based in Czechia, United Kingdom and Denmark. Ladislav Machala's co-authors include Petr Kodym, Jan Konvalinka, David Jilich, Jens Lundgren, Pavlína Řezáčová, Marek Malý, Jana Pokorná, H Rozsypal, Ondřej Beran and Amanda Mocroft and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and The Journal of Infectious Diseases.

In The Last Decade

Ladislav Machala

40 papers receiving 738 citations

Peers

Ladislav Machala
K. Squires United States
K. H. Mayer United States
Jerome Ernst United States
Joyce Jones United States
Joe Eron United States
Ladislav Machala
Citations per year, relative to Ladislav Machala Ladislav Machala (= 1×) peers Faïza Ajana

Countries citing papers authored by Ladislav Machala

Since Specialization
Citations

This map shows the geographic impact of Ladislav Machala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ladislav Machala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ladislav Machala more than expected).

Fields of papers citing papers by Ladislav Machala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ladislav Machala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ladislav Machala. The network helps show where Ladislav Machala may publish in the future.

Co-authorship network of co-authors of Ladislav Machala

This figure shows the co-authorship network connecting the top 25 collaborators of Ladislav Machala. A scholar is included among the top collaborators of Ladislav Machala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ladislav Machala. Ladislav Machala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jilich, David, et al.. (2021). Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons. Epidemiology and Infection. 149. e41–e41. 2 indexed citations
2.
Kowalska, Justyna, Anna Vassilenko, Arjan Harxhi, et al.. (2020). The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe. International Journal of Infectious Diseases. 104. 293–296. 15 indexed citations
3.
Rob, Filip, Kateřina Jůzlová, Daniela Vaňousová, et al.. (2019). Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis: a single-centre, cross-sectional study. Central European Journal of Public Health. 27(4). 285–291. 12 indexed citations
4.
Trejbalová, Kateřina, Jana Blažková, Ladislav Machala, et al.. (2016). Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals. Clinical Epigenetics. 8(1). 19–19. 51 indexed citations
5.
Kodym, Petr, Marek Malý, Ondřej Beran, et al.. (2014). Incidence, immunological and clinical characteristics of reactivation of latentToxoplasma gondiiinfection in HIV-infected patients. Epidemiology and Infection. 143(3). 600–607. 44 indexed citations
6.
Rozsypal, H, et al.. (2013). Doporučený postup péče o dospělé infikované HIV a postexpoziční profylaxe infekce HIV. 19(2). 1 indexed citations
7.
Machala, Ladislav, Marek Malý, Ondřej Beran, David Jilich, & Petr Kodym. (2013). Incidence and clinical and immunological characteristics of primary Toxoplasma gondii infection in HIV-infected patients. International Journal of Infectious Diseases. 17(10). e892–e896. 16 indexed citations
8.
Jilich, David, et al.. (2011). Prevalence of Human Leukocyte Antigen (HLA)-B*5701 in HIV-infected Subjects in Czech Republic. Central European Journal of Public Health. 19(3). 128–130. 3 indexed citations
9.
Machala, Ladislav, et al.. (2010). Kvalita života HIV pozitivních osob. 4(2). 22–40. 1 indexed citations
10.
Rozsypal, H, et al.. (2010). Bilateral Holmes–Adie syndrome as an early manifestation of the HIV neuropathy. Neurological Sciences. 31(5). 661–663. 4 indexed citations
11.
Reekie, Joanne, Amanda Mocroft, Bruno Ledergerber, et al.. (2010). History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change*. HIV Medicine. 11(7). 469–478. 23 indexed citations
12.
Bělohlávek, Jan, Petr Kuchynka, Ladislav Machala, et al.. (2009). Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis. Current HIV Research. 7(4). 434–436. 1 indexed citations
13.
Reekie, Joanne, Amanda Mocroft, Ladislav Machala, et al.. (2008). Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?. AIDS. 22(17). 2381–2390. 25 indexed citations
14.
Šašková, Klára Grantz, Milan Kožíšek, Martin Lepšı́k, et al.. (2008). Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Protein Science. 17(9). 1555–1564. 19 indexed citations
15.
Kowalska, Justyna, Amanda Mocroft, Anders Blaxhult, et al.. (2007). Current Hemoglobin Levels Are More Predictive of Disease Progression Than Hemoglobin Measured at Baseline in Patients Receiving Antiretroviral Treatment for HIV Type 1 Infection. AIDS Research and Human Retroviruses. 23(10). 1183–1188. 11 indexed citations
16.
Kodym, Petr, et al.. (2006). Prevalence and Incidence of Toxoplasma Infection in HIV‐Positive Patients in the Czech Republic. Journal of Eukaryotic Microbiology. 53(s1). S160–1. 7 indexed citations
17.
Václavíková, Jana, et al.. (2005). Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir. Journal of Clinical Virology. 33(4). 319–323. 3 indexed citations
18.
Phillips, Andrew, Bruno Ledergerber, Andrzej Horban, et al.. (2004). Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression. AIDS. 18(13). 1795–1804. 25 indexed citations
19.
Dragsted, Ulrik Bak, Amanda Mocroft, Stefano Vella, et al.. (2004). Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA Study. The Journal of Infectious Diseases. 190(1). 148–155. 47 indexed citations
20.
Weber, Jan, J.R. Mesters, Martin Lepšı́k, et al.. (2002). Unusual Binding Mode of an HIV-1 Protease Inhibitor Explains its Potency against Multi-drug-resistant Virus Strains. Journal of Molecular Biology. 324(4). 739–754. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026